Management of Patients With Skin Cancers: Basal Cell Carcinoma and Melanoma

Novel therapies are changing the treatment paradigm for both melanoma and advanced/metastatic basal cell carcinoma. While immunotherapies are increasing survival benefits in melanoma, they are associated with unique immune-related adverse events.

Detalles Bibliográficos
Autores principales: Hoffner, Brianna, Siegel, Daniel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003758/
https://www.ncbi.nlm.nih.gov/pubmed/29928546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003758/
https://www.ncbi.nlm.nih.gov/pubmed/29928546

Ejemplares similares